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Introduction {#sec1}
============

CD40L-CD40 interaction, one of the crucial interfaces between the innate and adaptive responses, plays a decisive role in modulating cytokines and consequential effector T cells in pathogenic responses, germinal center formation, affinity maturation, survival, proliferation, memory, autoimmunity, cancer, transplantations, and atherosclerosis ([@bib56]; [@bib39]; [@bib35]; [@bib23]). CD40L binding of CD40 results in multiple signaling events that lead to pleiotropic functions. The receptor CD40 lacks the kinase domain; it recruits TNF-α Receptor Associated Factors (TRAFs) at the cytoplasmic domain upon activation ([@bib44]; [@bib24]). The TRAFs activate the signaling pathways like Phosphatidylinositol 3-phosphate (PI3K), Raf, Lyn, Syk, p38, ERK, and Protein Kinase C (PKCs). Both TRAF-dependent and -independent signaling activate these signaling intermediates. CD40 signaling leads to activation of both canonical and non-canonical NF-κB pathways and of other associated Transcription Factors (TFs) such as ATF2, ELK1, BLIMP-1, BATF, and NFAT initiating differential gene expression and the ensuing effector function ([@bib14]; [@bib15]; [@bib42]; [@bib9]). CD40L-CD40 signaling is exploited by many pathogens for their survival; the switching of CD40 signaling to heighten the production of anti-inflammatory cytokines is a clear example ([@bib32]). During leishmanial infection, CD40 signaling is skewed toward the anti-inflammatory pathways involving cRaf, Syk, MEK1/2, ERK1/2, PKCδ, and PKCζ. However, stimulation with CD40L results in the skewing of the signaling toward pro-inflammatory pathway involving Lyn, PI3K, MKK3/6, p38, PKCα, and PKCβII ([@bib3]; [@bib20], [@bib21]; [@bib32]; [@bib34]; [@bib43]; [@bib50]). In addition, it was shown that LMP-1, a protein encoded by Epstein-Barr virus signaling like CD40, rescued certain functions---but not the full range---associated with the CD40 in CD40^−/−^ mice suggesting that there existed CD40L residue-specific signaling and functions ([@bib54]). Given the broad spectrum of signaling molecules activated by CD40 and its duality in pro- and anti-inflammatory responses, the origin of the specificity remains undetermined. Moreover, the cooperation and dissension between various signaling molecules in triggering gene expression and associated functions still remain to be uncovered. Therefore, it would be substantial in understanding the specific role of individual residues present on CD154 during the CD40 signaling and dissecting out the contribution in each pathway to carry out the effector function.

The complementarity-guided co-evolution of ligand-receptor systems often resulted in super-families of related ligands, implying the amino acid residue-specific interactions and continuous gain or loss of functions that relate to the evolutionary fitness ([@bib47]; [@bib40]; [@bib49]; [@bib12]; [@bib52]; [@bib48]). As mutation is a random process, any mutation that could lead to the loss of receptor binding and function were preferentially eliminated, keeping only those that favor the binding and specific function. CD40L mutations are associated with XIgM syndrome characterized by impaired B cells immunoglobulin class switching and recurrent infections of the affected individuals ([@bib46]; [@bib29]; [@bib61]). Although some of the CD40L mutations (deletion or nonsense) lead to truncated protein or improper folding to result in the loss of surface expression, there are point mutations that allow proper folding and surface expression of the CD40L but induce subtle yet substantial conformational changes to impede the CD40 signals. Reports suggest that the 115--155 amino acids stretch of CD40L is involved in the binding of the CD40 and are hotspots for mutations reported in XIgM ([@bib61]; [@bib5]; [@bib6], [@bib7]). Structural studies using bioinformatics tools and homology modeling revealed certain amino acids more critical during the interaction involving charged complementarities between the interacting residues in addition to hydrogen bonding. These included K133, E142, and K143, which has a direct role to pay in binding with CD40 and are charged. Moreover E129, K143, G144, Y145, and Y146 have a role in hydrophilic interaction with CD40 residues, whereas residue A130 has a hydrophobic interaction with CD40 receptor. Such interactions at this region (S128 to K149) are reported to be mutated in XIgM syndrome and are therefore implied in triggering CD40 signaling and effector functions ([@bib53]; [@bib19]; [@bib16]; [@bib2]).

As any of these mutations in XIgM led to similar deficiency in B cell function, the residue-specific message encoding in a ligand could not be envisaged. In order to decipher the specific messages encoded in each of these residues in the CD40L, we mutated each of these XIgM-implicated residues to valine and studied the changes in CD40 signaling and functions as compared with those triggered by wild-type CD40L. The profile of changes in all the assessed functions together defines the message encoded by the mutated amino acid. Herein, using CD40-CD40L as a model receptor-ligand system, we thus examine the residue-specific assignment of functions that also relate to the ligand-encoded messages that are transferred to the receptor during the receptor-ligand interaction.

Results {#sec2}
=======

The Point Substitutions Do Not Affect the Secondary Structures of the 41-mer Peptides {#sec2.1}
-------------------------------------------------------------------------------------

Originally discovered through B cell activation and survival,CD40-CD40L interaction was subsequently implicated in XIgM syndrome, characterized by hyper-IgM production and mutations in the CD40L 127--148 amino acid stretch ([@bib6], [@bib7]; [@bib5]; [@bib2]). As any of these mutations led to similar deficiency in B cell function, the idea of residue-specific function was never conceived. In order to decipher the specific messages encoded in each of these residues in the CD40L, we synthesized the 41-mer peptides (115--155 amino acids)---strongly homologous sequence between mice and humans ([Figure S1](#mmc1){ref-type="supplementary-material"})---with single XIgM-related amino acid substitutions to Valine and assessed their functions in mouse macrophages and their anti-leishmanial functions in susceptible BALB/c mice. Structure of 41-mer peptide was predicted using iTASSAR ([@bib41]) and is displayed as corresponding part of whole CD40L ([Figure 1](#fig1){ref-type="fig"}A). These substitutions, except in peptide 10, did not introduce any instability to the secondary structural differences as compared with the secondary structure of the wild-type ([Figures 1](#fig1){ref-type="fig"}B and 1C).Figure 1Details of Mutated Peptides and Their Position on the Protein Structure(A) Secondary structure of 41-mer CD40L and its position in the whole mouse CD40-ligand and the table mentioning the mutated amino acids (in red color) in the peptide chain.(B) The stick representation of the mutated residues on the 41-mer I-Tasser predicted peptide structures.(C) The variation in the structure conformation of each mutated peptide compared with the wild-type peptide by Superpose (wild-type peptide colored Red; mutated peptides have secondary structure color representation). The inset shows the root-mean-square deviation (RMSD) in the secondary structure of α-Carbon and the protein backbone in each mutated peptide compared with the wild-type peptide structure. The RMSD values are denoted with Å (Angstrom unit).See also [Figure S1](#mmc1){ref-type="supplementary-material"}.

Mutant Peptides Can Initiate Multiple Signaling Cascades {#sec2.2}
--------------------------------------------------------

We first assessed the CD40 signaling, as previously worked out ([@bib32]; [@bib50]; [@bib31]; [@bib3]), triggered by the wild-type and mutant CD40L peptides. We observed that, compared with the wild-type peptide, the peptides 7 and 8 induced higher p38MAPK, Lyn, PKCβII, and PKCα phosphorylation, whereas peptides 7, 9, and 10 induced higher PI3K phosphorylation. Peptide 7 induced higher MKK3/6 phosphorylation than that induced by the wild-type peptide ([Figures 2](#fig2){ref-type="fig"}A--2D, and [S2](#mmc1){ref-type="supplementary-material"}A--S2D). By contrast, ERK1/2, MEK1/2, Syk, and PKCζ phosphorylation was less induced by the peptides 7 and 8 than that induced by the wild-type. Mutant 5 induced higher MKK3/6 and cRaf, but less PKCβII, phosphorylation than that observed with the wild-type. Peptides 2, 3, 4, and 5 were least active in phosphorylating Lyn, Syk, PI3K, PKCα, PKCβII, PKCζ, MEK1/2, p38MAPK, and ERK1/2 ([Figures 2](#fig2){ref-type="fig"}A--2D and [S2](#mmc1){ref-type="supplementary-material"}A--S2D). The profile of collective signaling changes with each amino acid substitution thus identifying the signals associated with that particular residue in the wild-type.Figure 2Stimulation with CD40L Mutant Peptides Leads to Differential Activation of CD40 Downstream Signaling Molecules and Transcription Factor in Primary MacrophagesBALB/c mice were injected (i.p.) with 3% Thioglycolate, and peritoneal macrophages were obtained on day 5 post injections. These were cultured and rested for 36 h. These were stimulated with different mutant peptides at a concentration of 100 ng/mL. αCD40 NA/LE clone 3/23 antibody (6 μg/mL) was used as an experimental control. Protein lysate was prepared and subjected to western blotting to analyze the activation of different signaling intermediates.(A--E) (A) shows the activation of adaptor kinases Lyn and Syk, (B) shows the activation of serine/threonine kinases PI3K and c-Raf, (C) shows the activation of mitogen-activated protein kinases (MAP kinases), (D) PKCs, and (E) Transcription Factor. The immunoblots shown are representative of three independent experiments performed in duplicates showing similar results.(F) Heatmap of different signaling molecules and the transcription factors that are activated upon stimulation with the mutant peptides. The color bar quantitatively describes the fold change for each experimental observable for CC, P2 to P10 replacement; green represents up-regulation and red represents down regulation of expression of the represented observables in a given experimental setup. The values taken to generate the heatmap are based on the mean densitometry values (shown in the [Figures S2](#mmc1){ref-type="supplementary-material"}A--S2E). The experiments were performed thrice in duplicates, and results from one representative experiment are shown.See also [Figure S2](#mmc1){ref-type="supplementary-material"}.

Because the signals through kinases converge on the transcription factors that carry the message to the nucleus for effecting gene transcription and effector functions ([@bib9]; [@bib4]; [@bib26]; [@bib42]; [@bib45]; [@bib51]), we assessed the phosphorylation of key transcription factors in CD40 signaling. Peptides 7 and 8 showed the highest phosphorylation of IκBα, which upon phosphorylation relieves NF-κB to be activated by phosphorylation. Peptides 2, 5, and 10 activated IκBα to a lesser extent, whereas peptides 3, 4, and 9 could not activate IkBα. Peptides 7, 8, and 9 showed the highest ATF2 and ELK1 phosphorylation, whereas the other peptides activated only ELK1 but down-regulated ATF2. Peptide 8 activated NFAT the most, whereas peptides 4 and 5 activated NFAT the least ([Figures 2](#fig2){ref-type="fig"}E and [S2](#mmc1){ref-type="supplementary-material"}E). Such specificities in the activation of BATF, an AP1 family transcription factor, and BLIMP-1, a zinc finger protein transcription factor, were observed with these peptides ([Figures 3](#fig3){ref-type="fig"}A and 3B). It was observed that the expression of BATF was increased in the cells treated with the peptides 6 and 8, whereas rest of the peptides showed reduced expression. BLIMP-1 expression was highest in the cells pre-treated with peptides 5, 4, 2, and 3, whereas it was unchanged for peptide number 9 in comparison with the wild-type peptide. As summarized, the profiles of alterations in the signaling intermediates\' and transcription factors\' activation assign specificities to each of the substituted amino acids ([Figure 2](#fig2){ref-type="fig"}F).Figure 3Activation of Transcription factors BATF and BIMP-1 is Differentially Regulated by the Mutant PeptidesThioglycolate, 3%, was injected intraperitonial (i.p.) into BALB/c mice followed by harvesting of peritoneal macrophages after 5 days. These were cultured and rested for 36 h followed by stimulation with 100 ng/mL of mutant peptides for 48 h. The cells were harvested for FACS analysis to examine the expression of (A) BATF, a basic leucine zipper transcriptional factor ATF-like on CD11b^+^ gated population, and the significance was drawn from three independent experiments (represented as bar graph) where the error bars show mean ± SEM, and (B) BLIMP-1, a PR domain zinc finger protein 1, on CD11b^+^ gated population, and the significance was drawn from three independent experiments (represented in the bar graph) where the error bars show mean ± SEM. Data analysis for statistical significance was performed using one-way ANNOVA with Tukey\'s post-test where ∗p \< 0.05, ∗∗p \< 0.01,∗∗∗p ≤ 0.001; n.s., not significant. The results shown are representative of three independent experiments showing similar results.

Mutant Peptides Differentially Regulate PD-L1 Expression Modulating Cell Survival {#sec2.3}
---------------------------------------------------------------------------------

In order to comprehend functional consequence of the differential activation of signaling molecules, imparted owing to the peptides, we checked the expression of PD-L1 on CD11b^+^ macrophages. We could observe that the expression of PD-L1 was reduced in the macrophages that were treated with peptide 7 followed by peptide 8 and 6, whereas it was unchanged for the rest of the peptide stimulations. Since the production of different cytokines during the APC-T cell interaction has a range of outcome on the T cell subsets and its proliferation, survival, and effector function ([@bib18]), we performed macrophage-T cells co-culture. When CD4^+^CD44^dim^CD25^-^ naive T cells from CD40L^−/−^ mice were co-cultured with macrophages from C57BL/6 an increased production in IL-12 cytokine (data not shown) and decreased surface expression of PD-L1 on CD11b^+^ macrophages ([Figure 4](#fig4){ref-type="fig"}A) was evident along with subsequently restored production of IFNγ and proliferation of T cells ([Figures S3](#mmc1){ref-type="supplementary-material"}A and S3B) when treated with mutant peptide 7, 8, 6, and 9, respectively, in comparison with wild-type peptide as determined by FACS. Moreover, the peptides 7 and 8 were able to rescue the T cells from apoptosis as seen by Annexin-V and 7-AAD staining using FACS ([Figure 4](#fig4){ref-type="fig"}B). As CD40 was originally discovered helping B cell survival, we checked B cell survival ([@bib22]; [@bib57]) of these peptide-treated sterile-sorted CD19^+^IgD^+^ naive B cells from CD40L^−/−^ mice. AnnexinV/7-AAD staining showed that only Peptides 7 and 8, but not the others, enhanced survival and reduced apoptosis of B cells ([Figure 4](#fig4){ref-type="fig"}C).Figure 4Peptides Can Modulate the Expression of PD-L1 and Also Aids in the Survival of T cells and B cellsC57BL/6 mice were injected (i.p.) with 3% fluid Thioglycolate media and peritoneal-derived macrophages were obtained on day 5 post injections. These macrophages were rested for 36 h and then co-cultured with sterile sorter naive CD4^+^CD62L^−^CD25^−^T cells from CD40L^−/−^ mice at a ratio of 1:3 in round bottom 96-well plates along with the respective peptides for 48 h(A) Expression of PD-L1 on CD11b + cells of this co-culture system is shown, and the significance was drawn from three independent experiments (represented in the bar graph) where the error bars show mean ± SEM.(B) T cell apoptosis from the co-culture system, treated with respective peptides for 48 h, using 7-AAD and AnnexinV staining gated on CD4, the significance was drawn from three independent experiments (represented in the bar graph) where the error bars show mean ± SEM. Sterile sorted CD19^+^IgD^+^ naive B cells from CD154^−/−^ mice were treated with respective peptides for 48 h in round bottom 96-well plates.(C) B cell apoptosis using 7-AAD and AnnexinV staining from the peptide-treated B cells are shown, and the significance was drawn from three independent experiments (represented in the bar graph) where the error bars show mean ± SEM. Data analysis for statistical significance was performed using one-way ANNOVA with Tukey\'s post-test where ∗p \< 0.05, ∗∗p \< 0.01,∗∗∗p ≤ 0.001; n.s., not significant. The data shown are representative of three independent experiments.See also [Figure S3](#mmc1){ref-type="supplementary-material"}.

Mutant Peptides Alter the Expression of CD40-Regulated Genes that Affect Cell Membrane {#sec2.4}
--------------------------------------------------------------------------------------

Because CD40 signal-induced effector functions are associated with cholesterol and ceramide in the membrane ([@bib17]; [@bib43]; [@bib30]), we checked the expression of HMG-CoA reductase (HMGCR) and ceramide synthase, the respective controlling enzymes, in BALB/c-derived elicited macrophages that were either uninfected or *L*. *major* infected. Peptides 6, 7, and 8 augmented HMGCR, but reduced ceramide synthase, expression, whereas peptides 2, 3, 4, 5, and 10 increased ceramide synthase, but not HMGCR, expression in both uninfected and *L*. *major*-infected macrophages ([Figures 5](#fig5){ref-type="fig"}A and 5B). HMGCR expression correlated with the peptides-induced alterations in the levels of cholesterol in macrophages ([Figure 5](#fig5){ref-type="fig"}C). As CD40 induces expression of inducible nitric oxide synthase (iNOS) ([@bib3]), we checked expression of iNOS and arginase, which competes with iNOS for the common substrate L-arginine, in BALB/c-derived elicited macrophages in the presence of these peptides ([Figures 5](#fig5){ref-type="fig"}D and 5E). We observed that peptides 7 and 8, but not peptide 6, increased iNOS but reduced arginase expression, as compared with the wild-type peptide, in both uninfected and *L*. *major*-infected macrophages.Figure 5Functional Differences in CD40 Owing to Activation with Different Mutant Peptides of CD154BALB/c mice were injected (i.p.) with 3% fluid Thioglycolate media, and peritoneal-derived macrophages were obtained on day 5 post injections. These were cultured and rested for 36 h. Cells were either left uninfected or infected with L. *major* promastigotes as explained in [Transparent Methods](#mmc1){ref-type="supplementary-material"}. Cells were stimulated with different mutant peptides at a concentration of 100 ng/mL for 48 h. Cells were harvested and flow cytometry as explained in [Transparent Methods](#mmc1){ref-type="supplementary-material"} was performed to the expression on CD11b + gated cells. Expression of (A) HMGCR controlling the rate-limiting step during Cholesterol synthesis and the significance drawn from three independent experiments (represented in the bar graph) where the error bars show mean ± SEM, (B) ceramide synthase involved in the catalysis of ceramide, and the significance was drawn from three independent experiments (represented in the bar graph) where the error bars show mean ± SEM, (C) expression of membrane cholesterol using Filipin as cholesterol-binding dye and the significance drawn from three independent experiments (represented in the bar graph) where the error bars show mean ± SEM, (D) expression of iNOS regulating the expression of NO (Nitric Oxide), and the significance was drawn from three independent experiments (represented in the bar graph) where the error bars show mean ± SEM, (E) expression of Arg-1, which is associated with the expression of NO, and the significance was drawn from three independent experiments (represented in the bar graph) where the error bars show mean ± SEM. The upper panel shows uninfected macrophages, whereas the lower panel shows infected macrophages. Data analysis for statistical significance was performed using one-way ANNOVA with Tukey\'s post-test where ∗p \< 0.05, ∗∗p \< 0.01, ∗∗∗p ≤ 0.001; n.s., not significant. Results shown are representative of three independent experiments.

Because production of cytokines is associated with CD40-CD40L interaction ([@bib32]; [@bib3]; [@bib43]), we assessed the production of IL-1β, IL-6, IL-10, IL-12, TNF-α, and TGF-β by these CD40L peptides. Peptides 6, 7, and 8 induced higher IL-12, IL-1β, IL-6, IL-12, and TNF-α, but less IL-10 and TGF-β, production from thioglycolate-elicited peritoneal macrophages, whereas the other peptides failed to enhance these cytokines\' production ([Figures 6](#fig6){ref-type="fig"}A and 6B). These results were also in line with the control of *Leishmania* amastigotes in macrophages and nitrite production ([Figures 6](#fig6){ref-type="fig"}C--6E).Thus, fine functional specificities of peptide ligands can be used for selective regulation of a receptor\'s functions.Figure 6Mutant Peptides of CD154 Can Induce Differential Expression of Cytokine in Both Un-infected and Infected Macrophages Which Also Helps in the Control of Intracellular ParasitesBALB/c mice were injected (i.p.) with 3% fluid Thioglycolate media and peritoneal-derived macrophages were obtained on day 5 post injections. These were cultured and rested for 36 h. Cells were either left uninfected or infected with L. *major* promastigotes for 36 h as explained in [Transparent Methods](#mmc1){ref-type="supplementary-material"}. Cells were stimulated with different mutant peptides at a concentration of 100 ng/mL for 72 h and the supernatant was assessed for cytokine production using ELISA.(A) Shows the expression of IL-1β, IL-6, TNF-α, TGF-β, IL-10, and IL-12 in uninfected mice macrophages.(B) Shows the expression of these cytokines in *L*. *major*-infected mice macrophages. The data shown are representative of three independent experiments and error bars show mean ± SEM. Data analysis for statistical significance was performed using one-way ANNOVA with Tukey\'s post-test where ∗p \< 0.05, ∗∗p \< 0.01, ∗∗∗p ≤ 0.001; n.s., not significant. BALB/c mice were injected (i.p.) with 3% fluid Thioglycolate media and peritoneal-derived macrophages were obtained on day 5 post injections. These were cultured and rested for 36 h. Cells were either left uninfected or infected with L. *major* promastigotes for 36 h as explained in [Transparent Methods](#mmc1){ref-type="supplementary-material"}. Cells were stimulated with different mutant peptides at a concentration of 100 ng/mL for 72 h(C) Shows the numbers of *L*. *major* amistigotes/100 macrophages (parasite load assay explained in materials and methods) in infected macrophages using Giemsa staining. The data shown are representative of three independent experiments and error bars show mean ± SEM. Data analysis for statistical significance was performed using one-way ANNOVA with Tukey\'s post-test where ∗p \< 0.05, ∗∗p \< 0.01,∗∗∗p ≤ 0.001; n.s., not significant.(D) Resting macrophages were infected with CFSE-labeled stationary phase *L. major* promastigotes for 8 h. Unbound parasites were washed and cells were kept for 48 h. Respective peptides (P1, P6, P7, and P8) 100 ng/mL and αCD40 NA/LE clone 3/23 antibody 6 μg/mL were used to stimulate the cells for 72 h after which cells were stained for the nuclear stain using Hoechst 33342 and confocal images were captured on Leica SPII machine under 100X oil immersion lens. The experiments were performed at least thrice, and one of the representatives is shown in the figure.(E) NO production in the culture supernatant of *L*. *major*-infected macrophages stimulated with the peptide for 72 h (100 ng/mL) was assessed using Griess reagent. The data shown are representative of three independent experiments and error bars show mean ± SEM.

Treatment with Peptide7 or Peptide8 Rescues the CD40L^−/−^ Mice from *L*. *major* Infection {#sec2.5}
-------------------------------------------------------------------------------------------

Because each interacting amino acid residue in a receptor-ligand interaction can trigger a trail of signaling events that can affect anti-leishmanial functions of CD40, we examined whether these peptides regulated anti-leishmanial functions of macrophages and in BALB/c mice. Because CD40-CD40L interaction was shown to exert anti-leishmanial functions ([@bib32]; [@bib50]; [@bib3]; [@bib43]), we assessed the anti-leishmanial functions of these peptides in CD40L-deficient mice on C57BL/6 background. We infected these mice with *L*. *major* promastigotes at the hind footpad, followed by treatment with the peptides on days 1, 3, 5, and 7 post infection. Maximum protection against the infection was offered by peptides 7 and 8, followed by peptides 6 and 9 ([Figures 7](#fig7){ref-type="fig"}A and [S4](#mmc1){ref-type="supplementary-material"}A). The real-time PCR with the RNA extracted from the draining lymph node cells showed distinct profiles of IL-10, IL-12, IL-4, IFN-γ, IL-1β, IL-6, TNF-α, Arginase, and NO ([Figures 7](#fig7){ref-type="fig"}B and [S4](#mmc1){ref-type="supplementary-material"}B). When pulsed with leishmanial antigens, lymph node cells from the peptide 7- or 8-treated mice showed reduced IL-10 production but heightened IL-12 and IFN-γ ([Figure 7](#fig7){ref-type="fig"}C). The lymph node cells from the peptides 7 and 8-treated mice efficiently cleared parasites from the co-cultured *L*. *major*-infected macrophages ([Figure S4](#mmc1){ref-type="supplementary-material"}C); peptides 6 and 9 had less efficiency but the other peptides did not have any effect. This was further supported by the increased production of pro-inflammatory cytokine IL-12, IFN-γ, and nitrite production along with reduced IL-10 production ([Figure 7](#fig7){ref-type="fig"}D). These lymph node cells from the mice treated with peptide 7 or peptide 8 had higher t-Bet^+^CD4^+^ T cells but fewer RoRγt^+^CD4^+^ T cells ([Figures 7](#fig7){ref-type="fig"}E and [S4](#mmc1){ref-type="supplementary-material"}D). These results show that the messages encoded in a given residue can be altered by residue-specific mutations to generate a host-protective agonist of CD40L displaying unique collective cytokine expression profiles.Figure 7Treatment with Peptides 7 and 8 Confers Protection against *L*. *major* in CD40L-Deficient MiceStationary phase *L*. *major* promastigotes (2 × 10^6^) were injected subcutaneous injection (s.c.) at the hind footpad of CD40L^−/−^ mice on a C57BL/6 background. Mutant peptide at a dose of 6 mg/kg/mice in HBSS was administered to the mice (i.p.) mode on day 1, 3, 5, and 7 post infection.(A) The footpad swelling of the infected mice (n = 5) was monitored till sixth week and shown as line graph (upper panel). Mice were sacrificed on the sixth week and the popliteal lymph node was collected and the parasite burden was checked (lower panel). Results shown are representative of three independent experiments with similar results.(B)Heatmap showing relative expression of different pro- and anti-inflammatory cytokines elements from the lymphocytes obtained from the mice treated with CD154 mutants with P2 to P10 replacement. Fold change over P1 (as explained in [Methods](#sec4){ref-type="sec"}) is shown here on a log2 scale. The color bar quantitatively describes the fold change for each experimental observable for P2 to P10 replacement; green represents up-regulation and red represents down-regulation of expression of the represented observables in a given experimental setup. The results shown are representative of three independent experiments showing similar results. Lymphocytes were cultured in the presence of Crude Soluble Antigen (CSA) for 72 h and the supernatant was used to check the expression of cytokines IL10, IL12, and IFN-γ.(C) The data shown are representative of three independent experiments and error bars show mean ± SEM. Statistical significance of the differences between the means was assessed by one-way ANNOVA with Tukey\'s post-test where ∗p \< 0.05, ∗∗p \< 0.01, ∗∗∗p ≤ 0.001; n.s., not significant. C57BL/6 macrophages were infected with stationary phase *L*. *major* promastigotes at a macrophage:parasite ratio of 1:10 for 8 h. Unbound parasites were washed and macrophages were rested for 48 h. Lymphocytes obtained from the peptide-treated mice were co-cultured with these *L*. *major*-infected macrophages along with CSA (10 μg/mL) for 72 h, and the supernatant was subjected to cytokine ELISA.(D) IL10, IL12, IFN-γ, and NO contents in the supernatants are shown. The data shown are representative for three independent experiments and error bars show mean ± SEM. Data analysis for statistical significance was performed using one-way ANNOVA with Tukey\'s post-test where ∗p \< 0.05, ∗∗p \< 0.01,∗∗∗p ≤ 0.001; n.s., not significant.(E) The lymphocytes from similar treated group were pooled and subjected to FACS analysis to examine the expression of t-Bet expressing Th1 and RoR-γt expressing Th17 gated on CD4^+^CD44^+^CD62L^−^ T cell subsets. The percentage positive cells and the mean fluorescent intensity (MFI) in the gated population are shown. The data shown are representative of three independent experiments showing similar results.See also [Figure S4](#mmc1){ref-type="supplementary-material"}.

Mutations Affect Electrostatic Surface Potential and Predict Variable Interfacing Contacts {#sec2.6}
------------------------------------------------------------------------------------------

Because conformational complementarity is at the root of all receptor-ligand interactions, we first tested whether the peptides had any structural disorders. Analyses of the structures by DisEMBL ([@bib27]), GlobPlot ([@bib28]), and PONDR ([@bib60]) did not detect any structural disorder. Next, analyses of the secondary structures of these peptides by Molprobity ([@bib58]) and PROBE and visualization by KiNG ([@bib10]) identified that these substitutions brought subtle characteristic changes in their structures ([Figure S5](#mmc1){ref-type="supplementary-material"}). Electrostatic surface potential charge analysis identified induction of positive electrostatic surface potential in Pep2, Pep3, and Pep6 but negative surface potential in the Pep7 and Pep10, as compared with wild-type peptide ([Figure S6](#mmc1){ref-type="supplementary-material"}). Hydrogen bond types (N-H ... O, O-H ... O, and C-H ... O) were found between the residues of receptor and ligand. The S127 (Ser12) residue of peptides is prominent in all the interactions. Among all peptides, a common interaction pattern existed between Y30-E168 and T31-S166 of the CD40-Pep6, CD40-Pep7, and CD40-Pep8 receptor-ligand dockings and peptide ([Figure 8](#fig8){ref-type="fig"}).Figure 8CD40-CD40L (41-mer Peptides) Predicted Docking ModelThe electron cloud model of the structural features of the CD40 receptor and CD40L 41-mer peptides docked complexes. The color-coded structures are according to secondary structural features, and the cloud color depicts surface charge potential (red, negative charge; blue, positive charge). Interactions are shown as green dash line for classical hydrogen bonds, orange dash line for salt bridges. Comparative docking shows different interacting partners among complexes and against wild-type peptide-CD40 complex. Among specific interacting patterns in each complex, CD40-Pep6, CD40-Pep7, and CD40-Pep8 share Asn17-Met132, Ty30-Ser166, and Thr31-Glu168 interactions. Each interacting region shows distinctive impact on the complex surface charge potential. See also [Figures S5](#mmc1){ref-type="supplementary-material"} and [S6](#mmc1){ref-type="supplementary-material"}.

Discussion {#sec3}
==========

The classical studies on the interactions between peptide hormones and their transmembrane receptors involved mutation of a length of the gene or site-directed mutagenesis to ascertain that a particular stretch of the primary structure or specific amino acid of the hormone was required for the chosen assay to determine the peptide hormone activity. Such approaches suffered from the assumption that the chosen assay for the hormone activity represented all activities of the hormone, although the hormones used to be known as pleiotropic. Therefore, whether each of the function-inducing amino acids on the hormone would encode a specific message and would thus collectively impart the pleiotropic functions onto the hormone remained unknown. Thus, although transmembrane receptor-ligand interactions involve interactions between specific amino acids in ligand and the receptor, their specific roles distributed in different functions triggered by the receptor is never described. Indeed, the mutation of any of the reported nine residues led to XIgM syndrome suggesting their functional redundancy. The alternative possibility is that each of these nine amino acid residues triggers different signaling pathways that converge onto the mainstay of the receptor signaling such that the messages could be different but the final effector functions would be same. In this case, therefore, each amino acid substitution to 115--155 peptide ligand should have resulted in similar changes in the signaling and functions. By contrast, we decipher distinct collective profiles of changes for each of the amino acids substituted in the mutant CD40L. Our data suggest that each of these residues triggers specific CD40 signaling and induces a specific combination of cytokines and other effector responses in addition to the B cell survival. These residue-specific changes in the function were also observed in *Leishmania*-infected macrophage, which targets the CD40-associated signaling and gene expression. The study by Dadgostar et al. suggested differential regulation of CD40-associated genes as a virtue of independent, synergistic, and redundant control by CD40 stimulation ([@bib11]); however, the factors that dictate the aforementioned were not examined. We propose these factors to be individual residues having an independent, collective, and redundant control over the signaling, the output of which is a specific set of function, as evident by differential signaling and effector functions.

Although any of these mutations resulted in impaired IgM class switching to IgG in B cells ([@bib7]; [@bib53]), here a mutation does not necessarily impair all functions similarly in macrophages. Whether these peptides will show similar alterations in B cells proliferation, cytokine production, and phenotypic changes requires an independent study, but herein the B cell survival was not equally affected by all mutant CD40-L peptides: peptide 7 and peptide 8 did rescue the B cells from apoptosis. As B cells and macrophages belong to different lineages of hematopoietic cells---lymphocytic and myeloid, respectively---the reason for differences between B cells and macrophages could simply be differences in constitutive expression of genes or cell-specific genetic repression program. The other possible mechanisms of the observed difference could be many: differences in the membrane lipids in which the receptor is embedded, expression of the receptor-associated molecules or the expression of signaling molecules, or the threshold of activation of these molecules, particularly those involved in cell survival or even in the post-translational modification of proteins or cell-specific protein expressions. However, an independent study is required to settle how CD40 functions in B cells can be different from that in macrophages.

Structurally, such mutations may represent altered positioning of each of the other contact residues with their counterparts in CD40 receptor or localized disruption of the residue-specific interactions between the target (substituted) residue on the ligand and its interacting residue on CD40. As we did not observe any major structural changes in any of the substituted peptides, it is unlikely that one substitution alters all interactions. As a result, it is very likely that the substituted amino acid will alter only its specific interaction and will therefore alter the functions associated with this residue. Compared with the functions associated with the wild-type CD40L, each mutation caused specific functional alteration profiles that collectively assigned the functional specificity to the residue. Moreover, the residue-specific interaction of CD40L with other receptors such as integrin family and sharing common signaling intermediates like TRAFs and MAPKs would modulate the signaling pathway and signal strength ([@bib13]; [@bib25]).Therefore, the message encoded in each of the residues in CD40L peptides relates to the collective profiles of functions, which could be the result of specific combinations of signaling.

It is plausible that CD40L peptides\' binding to CD40 induces a wave of structural changes in CD40 and is relayed to the intracellular domain where the signaling molecules including adaptors such as TRAF are recruited ([@bib33]; [@bib1]). Contingent upon this signalosome complex, the subsequent signaling network is determined. CD40 is reported to bind TRAFs with varying avidity through the TRAF-binding domains, which are exposed owing to ligand binding activation and CD40 clustering ([@bib38], [@bib36], [@bib37]). The stoichiometry of the TRAF-binding domains depends on the interacting residues of CD40L-CD40 interphase resulting in the complete or restricted exposure of this domain thereby differentially recruiting TRAF protein having different signaling outcomes. The presence of preformed CD40 clusters with itself and another tumor necrosis factor receptor (TNFR) family can also change the binding stoichiometry with incoming residues on the ligand. It is plausible that the message encoded in one residue of the ligand is to induce very specific profiles of structural changes to the receptor eventuating in combinations of different functions with specific amplitude and kinetic profiles. However, such cryptographic references are yet to appear. To the best of our knowledge, this is the first report that implies physical form of cryptography in a biological system.

These peptides also differentially regulate the induction of PD-L1, an inhibitory molecule that can be blocked to derive an anti-leishmanial function ([@bib18]; [@bib8]), and the peptides that down-regulate PD-L1 also elicit host-protective anti-leishmanial T cell response. A specific residue in a ligand can thus have functional integration of the elicited signals with the subsequent events that can be immuno-regulatory. Therefore, our data imply that, instead of blocking the downstream PD-L1-mediated pro-leishmanial functions, the therapy can be the upstream choice of engineered ligands with the residues that reduce PD-L1 expression. The identification of different pockets on the CD40 receptor can be exploited for targeted signaling modulations that are elicited by CD40 opening up a new avenue for the structure-function relationship for targeted drug discovery ([@bib55]). The use of small peptides and molecules will also overcome the limitations such as thromboembolic unfavorable effects associated with use of anti-CD40 antibody ([@bib59]). Our data not only uncover the novel message encoding in each amino acid and its decoding by intracellular signaling but also, as they lead to residue-specific effector functions profile, provide a scientific rationale for designing an immuno-therapeutic strategy. In essence, this is the first demonstration of the residue-specific message encoding system and decoding of messages by signaling intermediates. At this moment, the technical limitations do not allow mapping the atomic changes in the interacting residues. An online mapping of such changes in the interacting receptor and its ligand will lead to the next level of cryptography.

Limitations of the Study {#sec3.1}
------------------------

In this study we have shown that residues trigger specific CD40 signaling and induce a specific combination of cytokines and other effector responses in addition to the B cell survival. Although any of these mutations resulted in impaired IgM class switching to IgG in B cells, here a mutation does not necessarily impair all functions similarly in macrophages. However, we do not know whether these peptides will show analogous alterations in B cells proliferation, cytokine production, and phenotypic changes for which an independent study will be required. The reason for differences between B cells and macrophages could be many: differences in the membrane lipids in which the receptor is embedded, expression of the receptor-associated molecules or the expression of signaling molecules, or the threshold of activation of these molecules, particularly those involved in cell survival or even in the post-translational modification of proteins or cell-specific protein expressions. In addition, the involvement of these residues during germinal center formation will be fateful in the affinity maturation and memory T cell formation owing to differential signaling and activation of genes resulting in recruitment of follicular dendritic cells, a prerequisite for germinal center formation. However, an independent study is necessary to reconcile how CD40 functions in B cells can be dissimilar from that in macrophages.
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